The Conversion Problem With Retinol
Vitamin A is one of the most studied actives in skincare, and one of the most misunderstood. The confusion often starts with the word “retinol” being used as a catch-all, when in fact the vitamin A family includes retinol, retinaldehyde, retinoic acid, and several other derivatives, each requiring a different number of enzymatic conversion steps before the skin can use it.
Retinol, the form found in most over-the-counter products, must convert to retinaldehyde, then to retinoic acid. That is two steps. Retinaldehyde converts to retinoic acid in one step. This single-step conversion is why retinaldehyde works closer to prescription-strength results without requiring a prescription or triggering the same degree of irritation.
Why Encapsulation Changes the Calculation
Encapsulation is a delivery mechanism, not a marketing term. In the context of vitamin A, it refers to wrapping the active molecule in a protective shell that controls how and when it is released into the skin.
The practical effect is slow release across 8 to 12 hours, meaning the skin receives a steady, controlled dose rather than a concentrated hit at application. This matters for several reasons.
First, the irritation associated with conventional retinol and retinaldehyde is largely dose-dependent. A large amount of active arriving in a short window is more likely to trigger peeling, redness, and disruption to the barrier. Slow release distributes that same dose across a longer period.
Second, encapsulation enables twice-daily use. Most retinol products are recommended for PM use only, in part because of photosensitivity concerns and in part because of how the skin responds to the immediate release. An encapsulated 1% retinaldehyde can be used in both morning and evening routines without the same risk profile.
Third, stability is significantly improved. Retinaldehyde degrades when exposed to light and air. Encapsulation protects the molecule until it is in contact with the skin, which means what is on the label is what is being delivered.
What This Means for a Routine
For someone building a routine around professional-grade skincare, the distinction between retinol and encapsulated retinaldehyde matters in practice. A formula that uses 1% encapsulated vitamin A, alongside 10% encapsulated vitamin B3 and 5% vitamin C superfruit extract, is able to address skin cell renewal, pigmentation, and collagen support simultaneously, without requiring the skin to tolerate the irritation typically associated with high-dose vitamin A.
The encapsulation protocol also makes it suitable for sensitive skin, which is not typically the case with conventional retinaldehyde at this concentration. The slow release allows the skin to adapt over time rather than reacting to an immediate chemical signal.
The 8 to 12 Hour Window
One detail worth understanding is how the timing works. An encapsulated vitamin A formula applied at 7am continues releasing its active payload through the late afternoon or early evening. A PM application carries through to early morning. The result is continuous active delivery throughout the 24-hour cycle, which is closer to how the skin’s own repair mechanisms operate than a twice-daily spike and trough.
This kind of delivery is what separates a formulation built around encapsulation from one that adds encapsulation as a label feature. The dose, the timing, and the compatibility with other actives all need to be considered in the design of the formula, not applied as an afterthought.

Mathew Hicks is a world-renowned author and expert in the field of business and finance. He has written multiple books and articles on the subject and has been featured in numerous publications. His expertise has been sought by leading financial institutions around the world.
